Session: Confronting Drug-Resistant Tuberculosis Head On (Fifth Decennial International Conference on Healthcare-Associated Infections (March 18-22, 2010))

Friday, March 19, 2010: 2:00 PM-3:30 PM

International North-South (Hyatt Regency Atlanta)

CME Credits: 1.50

Type: Oral

Summary: Patients with drug-resistant TB, particularly XDR-TB, are left with treatment options that are much less effective and often have worse clinical outcomes. This session will review the global epidemiology of drug-resistant TB, existing data on drug-resistant TB, including XDR-TB, outbreaks associated with healthcare facilities, and infection control techniques, including novel methods, for reducing nosocomial transmission of drug-resistant TB.

Learning Objectives:

Describe the epidemiology of drug-resistant TB and the global emergence of XDR-TB.
Summarize existing data on drug-resistant (including XDR) TB outbreaks in healthcare settings.
Summarize evidence on effectiveness of infection control measures, including novel techniques for preventing spread of drug-resistant (including XDR) TB.

Co-Organized by:

the International Federation of Infection Control (IFIC)

Moderators:

Anucha Apisarnthanarak, MD and Kent Sepkowitz

2:00 PM

333

The Global Epidemiology of XDR-TB in 2010: Challenges, Morbidity, and Anticipated Burden
J. Peter Cegielski, MD, MPH, Centers for Disease Control and Prevention

2:30 PM

334

XDR-TB Outbreaks in Healthcare Settings
Neel Gandhi, MD, Albert Einstein College of Medicine

3:00 PM

335

Infection Control Issues Specific to XDR-TB
Henry Blumberg, MD, Emory University School of Medicine

41 Confronting Drug-Resistant Tuberculosis Head On